Soleno Therapeutics (SLNO) Assets Average (2016 - 2019)
Historic Assets Average for Soleno Therapeutics (SLNO) over the last 6 years, with Q3 2019 value amounting to $31.4 million.
- Soleno Therapeutics' Assets Average fell 205.67% to $31.4 million in Q3 2019 from the same period last year, while for Sep 2019 it was $31.4 million, marking a year-over-year decrease of 205.67%. This contributed to the annual value of $41.1 million for FY2018, which is 8429.87% up from last year.
- According to the latest figures from Q3 2019, Soleno Therapeutics' Assets Average is $31.4 million, which was down 205.67% from $36.5 million recorded in Q2 2019.
- Soleno Therapeutics' 5-year Assets Average high stood at $41.0 million for Q1 2019, and its period low was $6.9 million during Q3 2016.
- For the 5-year period, Soleno Therapeutics' Assets Average averaged around $22.5 million, with its median value being $28.4 million (2017).
- In the last 5 years, Soleno Therapeutics' Assets Average tumbled by 2076.76% in 2016 and then skyrocketed by 37141.92% in 2017.
- Soleno Therapeutics' Assets Average (Quarter) stood at $7.7 million in 2015, then dropped by 10.43% to $6.9 million in 2016, then surged by 371.42% to $32.7 million in 2017, then grew by 13.12% to $37.0 million in 2018, then decreased by 15.04% to $31.4 million in 2019.
- Its Assets Average stands at $31.4 million for Q3 2019, versus $36.5 million for Q2 2019 and $41.0 million for Q1 2019.